sp-100030 and Hyperplasia

sp-100030 has been researched along with Hyperplasia* in 1 studies

Other Studies

1 other study(ies) available for sp-100030 and Hyperplasia

Article	Year
SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo. Transplantation proceedings, 1996, Volume: 28, Issue:6 Topics: Animals; Arthritis, Experimental; Body Weight; Dexamethasone; Female; Heart Transplantation; Hyperplasia; Immunosuppressive Agents; Isoantigens; Lymph Nodes; Lymphocyte Transfusion; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Organic Chemicals; Rats; Rats, Inbred Lew; Spleen; Transplantation, Heterotopic	1996

Article

Year

SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo.

Transplantation proceedings, 1996, Volume: 28, Issue:6

Topics: Animals; Arthritis, Experimental; Body Weight; Dexamethasone; Female; Heart Transplantation; Hyperplasia; Immunosuppressive Agents; Isoantigens; Lymph Nodes; Lymphocyte Transfusion; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Organic Chemicals; Rats; Rats, Inbred Lew; Spleen; Transplantation, Heterotopic

1996